Q3 Results Updates: Rossari Biotech Profit Slips 8%; ICICI Prudential Profit Rises To Rs 325 Crore
Tata Tech, Tanla Platforms, KEI Industries, and Dalmia Bharat are some of the companies releasing their quarterly number on Tuesday. Catch live updates here.
KEY HIGHLIGHTS
Q3 Results Live: Rossari Biotech Profit Down 8%
Rossari Biotech Q3 Highlights (Consolidated, YoY)
Revenue up 10.6% to Rs 513 crore versus Rs 464 crore.
Ebitda up 1.9% to Rs 64.7 crore versus Rs 63.5 crore.
Ebit margin at 12.6% versus 13.7%.
Net profit down 7.6% at Rs 31.7 crore versus Rs 34.3 crore.
Q3 Earnings Live: Tanla Platforms Profit Slips 9%
Tanla Platforms Q3 Highlights (Consolidated, QoQ)
Revenue down 0.03% to Rs 1,000 crore versus Rs 1,001 crore.
Ebit down 8.6% to Rs 139 crore versus Rs 152 crore.
Ebit margin at 13.9% versus 15.2%.
Net profit down 9% at Rs 119 crore versus Rs 130 crore.
Q3 Earnings Live: PNB Housing Profit Rises 36%
PNB Housing Finance Co Q3 Highlights (YoY)
Net income up 9.9% at Rs 1,925 crore versus Rs 1,751 crore.
Net profit up 36% at Rs 471 crore versus Rs 346 crore.
Q3 Earnings Live: ICICI Prudential Profit Rises 43%
ICICI Prudential Life Insurance Co Q3 Highlights
Net premium income up 23.49% at Rs 12,261 crore versus Rs 9,929 crore (YoY).
Net profit up 43.2% at Rs 325 crore versus Rs 227 crore (YoY).
Solvency Ratio at 211.8% versus 188.6% (QoQ).
13th month persistency at 85.8% versus 86.4% (QoQ).
Q3 Earnings Live: Stocks Outperforming Q3 Misses, As Per Jefferies
Despite more and more Indian corporates posting lower-than-expected numbers in the December quarter, Jefferies sees companies across sectors outperforming on their result day despite weak earnings. The brokerage believes the earnings miss has already been factored in these stocks.
Stocks in this list include Amber Enterprises India Ltd., KFin Technologies Ltd., Max Healthcare Institute Ltd., Chalet Hotels Ltd., Macrotech Developers Ltd., Coforge Ltd., Hindustan Petroleum Corp., United Spirits Ltd., Sonata Software Ltd., Poly Medicure Ltd., Jubilant FoodWorks Ltd., Persistent Systems Ltd., Mankind Pharma Ltd., and Syngene International Ltd.
